<DOC>
	<DOCNO>NCT00922740</DOCNO>
	<brief_summary>The main purpose study evaluate way VA106483 enter leave blood tissue time drug act body various dose level compare placebo volunteer .</brief_summary>
	<brief_title>VA106483 Dose Response Study Elderly Males</brief_title>
	<detailed_description>VA106483 intend use treatment patient suffer nocturia ( define wake urinate least per night period sleep ) . Nocturia condition often worsen sufferer get old . This may due over-active bladder muscle , bladder able hold less urine night-time production urine bladder night . The antidiuretic approve treatment ( country ) nocturia peptide drug , desmopressin . However , cause hyponatraemia proportion patient age 65 year contra-indicated elderly . This side-effect observed VA106483 , make potentially suitable treat elderly . The purpose study confirm duration action VA106483 effectively control dose therefore satisfactory clinical outcome treatment nocturia achieve individual dose titration . Subjects water-loaded , dose either VA106483 placebo urine production monitor assess anti-diuretic effect .</detailed_description>
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male , Age : 65 year Using adequate contraception Medical history without clinically significant pathology ; evidence serious pathology disease Physical examination parameter without sign serious disease No clinically significant ECG lab safety test ( sodium must within normal range ) Willing able participate provide write informed consent Cardiac insufficiency ; sign symptom suggestive heart failure require treatment diuretic Supine arterial blood pressure high 170/100 mmHg less 105/60 mm Hg Presence poorly control endocrine disorder Renal insufficiency , active hepatic and/or biliary disease Hyponatraemia . Serum sodium level must within normal limit Syndrome inappropriate antidiuretic hormone ( ADH ) secretion Symptoms suggestive psychogenic habitual polydipsia diabetes insipidus Known hypersensitivity IP constituent IP Use nonprescription preparation within 72 hour prior study entry , exception define pain killer A history alcohol abuse drug addiction within last 2 year Positive screen HIV , hepatitis B C Currently take diuretic concomitant medication know cytochrome 3A4 inhibitor Other protocol define eligibility criterion may apply .</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Nocturia</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Water-loading</keyword>
	<keyword>Elderly</keyword>
	<keyword>Males</keyword>
</DOC>